LifeSpan BioSciences Completes $19 Million in Financing For Expression Database | GenomeWeb

NEW YORK, April 17- LifeSpan Biosciences has raised $19 million in a third round of private financing, the company said Tuesday.

LifeSpan of Seattle, plans to use the new funds to automate and enhance its high-throughput gene expression analysis technology, launch new disease and gene family databases, including a cancer database, and fortify its gene research programs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."